RESEARCH ARTICLE
Nobel Med 2020; 16(3): 22-28
THE EFFECT OF INTRAVENOUS IRON SUCROSE TREATMENT ON MATERNAL HEMOGLOBINE LEVEL AND NEONATAL BIRTH WEIGHT
İrem Şenyuva, Serkan BodurABSTRACT
Material and Method: 97 pregnant women, who admitted to Usak Educational and Training Hospital Department of Obstetrics and Gynecology in 2015-2018, records were evaluated. Patients with IDA were included in this study and separated three groups according to started of iv iron sucrose treatment by gestational week(w). Group 1 (n=32): 21-31 w / group 2(n= 31) 32-35 w/group 3(n= 34) 36-38 w. All groups were compared in terms of demographic features, pre-treatment Hb and ferritine level, post -treatment Hb level at 15. day and birth, neonatal birth weight, week and APGAR score at birth.
Results: In all groups, post treatment 15. day and birth, increased Hb values up to border of anemia according to trimester was observed. There were not any significant differences between the groups in terms of post-treatment Hb level at 15. day and birth (Group 1/2/3, p=0,363/0,282/0,352). Target Hb value (≥12 g/dl) at birth was observed in group 1(12,1±0.9g/dl (10.1-14.5). Low birth weight, low APGAR score and preterm delivery were not observed in any groups (Grup 1/2/3, p=0,633/0,245/0,585).
Conclusion: Intravenous iron sucrose treatment rapidly increased maternal Hb value on the border of anemia by trimester in short time and there were not any negative effect on the neonatal birth weight.
Authors Orcid Profiles
Article Details
KNOWLEDGE AND BEHAVIOR OF MOTHERS LIVING IN MALATYA PROVINCE ABOUT BREASTFEEDING THEIR BABIES
05-12Gülsen Güneş, Gülsen Özdemir Ayhan, Burak Mete, Rukuye Aylaz
RESEARCH ARTICLE Nobel Med 2020; 16(3): 5-12THE COMBINED PERFORMANCE OF FECAL CALPROTECTIN WITH FECAL OCCULT BLOOD, LYMPHOCYTE AND NEUTROPHIL PERCENTAGES IN DISCRIMINATING ULCERATIVE COLITIS
13-21Esma Sürmen Gür, Özge Cindemir
RESEARCH ARTICLE Nobel Med 2020; 16(3): 13-21THE EFFECT OF INTRAVENOUS IRON SUCROSE TREATMENT ON MATERNAL HEMOGLOBINE LEVEL AND NEONATAL BIRTH WEIGHT
22-28İrem Şenyuva, Serkan Bodur
RESEARCH ARTICLE Nobel Med 2020; 16(3): 22-28HEPATITIS B SEROPREVELANCE IN MEDICAL ONCOLOGY PATIENTS
29-34Süreyya Gül Yurtsever, Selçuk Kaya, Tamer Arkalı, Tuba Müderris, Pelin Günaydın, Yüksel Küçükzeybek
RESEARCH ARTICLE Nobel Med 2020; 16(3): 29-34THE INVESTIGATION OF PHYSICIAN’S AND NURSE’S PERCEPTION OF THEIR PROFESSION PRACTICE USING METAPHORICAL ANALYSIS METHODS
35-49Şule Karadağ, Şerife Didem Kaya
RESEARCH ARTICLE Nobel Med 2020; 16(3): 35-49VITAMIN D LEVELS: DATA FROM THE EASTERN BLACK SEA REGION
50-55Abdullah Kaan Kurt, Cuma Ali Zoba, Yusuf Fikret Karateke, Turan Set, Elif Ateş
RESEARCH ARTICLE Nobel Med 2020; 16(3): 50-55SABUNCUOĞLU ŞEREFEDDIN (1385-1468) Amasyalı Şerefeddin
56-60Zafer Öztek
A PORTRAIT Nobel Med 2020; 16(3): 56-60LIVER AND SYSTEMIC DISEASES
05-09Sebati Özdemir
REVIEW Nobel Med 2013; 9(2): 5-9AGING KIDNEY: SENESCENCE OR DISEASE?
10-14Meltem Gürsu, Rümeyza Kazancıoğlu, Savaş Öztürk
REVIEW Nobel Med 2013; 9(2): 10-14IMPORTANCE OF HOLOTRANSCOBALAMIN (HOLOTC) MEASUREMENTS IN EARLY DIAGNOSIS OF COBALAMIN DEFICIENCY, ESPECIALLY IN PATIENTS WITH BORDERLINE VITAMIN B12 CONCENTRATIONS
15-20Faruk Sönmezışık, Esma Sürmen Gür, Burak Asıltaş
RESEARCH ARTICLE Nobel Med 2013; 9(2): 15-20EVALUATION OF PHYSICAL GROWTH IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
21-25Celalettin Koşan, Oğuzhan Sepetçigil, Atilla Çayır, Avni Kaya, Behzat Özkan
RESEARCH ARTICLE Nobel Med 2013; 9(2): 21-25COMPARISON OF RISK INDEXES USED IN DETERMINING THE POSTOPERATIVE RESPIRATORY INSUFFICIENCY RISK
26-31Gülsüm Kavalcı, Cavidan Arar, Alkın Çolak, Nesrin Turan, Cemil Kavalcı
RESEARCH ARTICLE Nobel Med 2013; 9(2): 26-31THE EVALUATION OF PRENATAL AND ENVIROMENTAL RISK FACTORS IN CHILDREN WITH ASTHMA, ALLERGIC RHINITIS AND BRONCHIAL ASTHMA ABSTRACT
32-37Mehmet İbrahim Turan, Müferet Ergüven, Mehmet Özdemir
RESEARCH ARTICLE Nobel Med 2013; 9(2): 32-37REOPERATIONS AND MORBIDITY IN THYROID SURGERY
38-42Serkan Teksöz, Murat Özcan, Aytül Sargan, Yusuf Bukey, Recep Özgültekin, Ateş Özyeğin
RESEARCH ARTICLE Nobel Med 2013; 9(2): 38-42EFFECTS OF RAMADAN FASTING ON BLOOD PRESSURE CONTROL, LIPID PROFILE, BRAIN NATRIURETIC PEPTIDE, RENAL FUNCTIONS AND ELECTROLYTE LEVELS IN HYPERTENSIVE PATIENTS TAKING COMBINATION THERAPY
43-46İbrahim Faruk Aktürk, İsmail Bıyık, Cüneyt Koşaş, Ahmet Arif Yalçın, Mehmet Ertürk, Fatih Uzun
RESEARCH ARTICLE Nobel Med 2013; 9(2): 43-46MANAGEMENT OF A LARGE OUTBREAK CAUSED BY NOROVIRUS AND CAMPYLOBACTER JEJUNI OCCURRED IN A RURAL AREA IN TURKEY
47-51İbak Gönen
RESEARCH ARTICLE Nobel Med 2013; 9(2): 47-51FREQUENT CD99 AND FLI-1 EXPRESSIONS IN DIFFUSE LARGE B-CELL LYMPHOMA AND THEIR ASSOCIATION WITH PROLIFERATIVE AND APOPTOTIC RATES
52-56Ufuk Berber, İsmail Yılmaz, Tolga Tuncel, Zafer Küçükodacı Aptullah Haholu
RESEARCH ARTICLE Nobel Med 2013; 9(2): 52-56-
Pubmed Style
İrem Şenyuva, Serkan Bodur. [THE EFFECT OF INTRAVENOUS IRON SUCROSE TREATMENT ON MATERNAL HEMOGLOBINE LEVEL AND NEONATAL BIRTH WEIGHT]. Nobel Med 2020; 16(3): 22-28, English. -
Web Style
İrem Şenyuva, Serkan Bodur. [THE EFFECT OF INTRAVENOUS IRON SUCROSE TREATMENT ON MATERNAL HEMOGLOBINE LEVEL AND NEONATAL BIRTH WEIGHT]. www.nobelmedicus.com/en/Article.aspx?m=1716 [Access: Mayıs 24, 2021], English. -
AMA (American Medical Association) Style
İrem Şenyuva, Serkan Bodur. [THE EFFECT OF INTRAVENOUS IRON SUCROSE TREATMENT ON MATERNAL HEMOGLOBINE LEVEL AND NEONATAL BIRTH WEIGHT]. Nobel Med 2020; 16(3): 22-28, English. -
Vancouver/ICMJE Style
İrem Şenyuva, Serkan Bodur. [THE EFFECT OF INTRAVENOUS IRON SUCROSE TREATMENT ON MATERNAL HEMOGLOBINE LEVEL AND NEONATAL BIRTH WEIGHT]. Nobel Med (2020); 16(3): 22-28, [cited Mayıs 24, 2021], English. -
Harvard Style
İrem Şenyuva, Serkan Bodur. (2020) [THE EFFECT OF INTRAVENOUS IRON SUCROSE TREATMENT ON MATERNAL HEMOGLOBINE LEVEL AND NEONATAL BIRTH WEIGHT]. Nobel Med, 16(3): 22-28, English.